Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
AntibioticsORALGeneric

BICILLIN

PENICILLIN G BENZATHINE

Standard Dose
300,000 UNITS/5ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: UNKNOWN Marketing status: Discontinued
Summary

Approval overview BICILLIN is listed in Drugs@FDA under application 050126 (NDA).

Review priority: UNKNOWN Marketing status: Discontinued Active ingredient PENICILLIN G BENZATHINE Form and strength SUSPENSION;ORAL - 300,000 UNITS/5ML Sponsor WYETH AYERST Submission history Latest submission status date: 1951-11-22 00:00:00.

Structured Monograph

Clinical summary

Approval overview BICILLIN is listed in Drugs@FDA under application 050126 (NDA). Review priority: UNKNOWN Marketing status: Discontinued Active ingredient PENICILLIN G BENZATHINE Form and strength SUSPENSION;ORAL - 300,000 UNITS/5ML Sponsor WYETH AYERST Submission history Latest submission status date: 1951-11-22 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: UNKNOWN

Interaction Notes

  • No interaction notes stored yet.